Christopher Baccei

Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268

Daniel S. Lorrain, Christopher Baccei, Linda J. Bristow et al. · Neuroscience · 2003 · 431 citations

Life Sciences, Neurobiology, Neuroscience +14

Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge

Daniel S. Lorrain, Hervé Schaffhauser, Una C. Campbell et al. · Neuropsychopharmacology · 2003 · 94 citations · Full text

Life Sciences, Neurobiology, Neuroscience +9

Phenyl-tetrazolyl Acetophenones:  Discovery of Positive Allosteric Potentiatiors for the Metabotropic Glutamate 2 Receptor

Anthony B. Pinkerton, Jean‐Michel Vernier, Hervé Schaffhauser et al. · Journal of Medicinal Chemistry · 2004 · 58 citations

Medicine, Neuroscience, Pharmacology +14

Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung

Karin J. Stebbins, Alex Broadhead, Christopher Baccei et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 48 citations

Life Sciences, Immunology, Pharmacology +17

5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- <i>tert</i> -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 <i>H</i> -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor

Nicholas Stock, Gretchen Bain, Jasmine Zunic et al. · Journal of Medicinal Chemistry · 2011 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10